Publication Cover
Nutritional Neuroscience
An International Journal on Nutrition, Diet and Nervous System
Volume 7, 2004 - Issue 5-6
56
Views
13
CrossRef citations to date
0
Altmetric
Articles

Ghrelin: A Link between Eating Disorders, Obesity and Reproduction

Pages 255-270 | Published online: 05 Sep 2013

References

  • Adeghate, E. and Ponery, A.S. (2002 ) “Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats”, Journal of Neuroendocrinology 14, 555–560.
  • Ahima, R.S. and Osei, S.Y. (200l) “Molecular regulation of eating behavior: new insights and prospects for therapeutic strategies”, Trends in Molecular Medicine 7, 205–213.
  • Allison, D.B., Fontaine, K.R., Manson, J.E., Stevens, J. and VanItallie, T.B. (1999 ) “Annual deaths attributable to obesity in the United States”, Journal of the American Medical Association 282, 1530–1538.
  • American Psychiatric Association “Eating Disorders” (2000) Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (Washington, DC), (Text revision), pp 583–596.
  • American Psychiatric Association Work Group on Eating Disorders (2000 ) “Practice guideline for the treatment of patients with eating disorders (revision)”, American Journal of Psychiatry 157, 1–39.
  • Argente, J., Caballo, N., Barrios, V., Munoz, M.T., Pozo, J., Chowen, J.A., Morande, G. and Hernandez, M. (1997 ) “Multiple endocrine abnormalities of the growth hormone and insulinlike growth factor axis in patients with anorexia nervosa: effect of short- and long-term weight recuperation”, Journal of Clinical Endocrinology and Metabolism 82, 2084–2092.
  • Arosio, M., Ronchi, C.L., Gebbia, C., Cappiello, V., Beck-Peccoz, P. and Peracchi, M. (2003 ) “Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels”, Journal of Clinical Endocrinology and Metabolism 88, 701–704.
  • Arvat, E., Maccario, M., Di Vito, L., Broglio, F., Benso, A., Gottero, C., Papotti, M., Muccioli, G., Dieguez, C., Casanueva, F.F., Deghenghi, R., Camanni, F. and Ghigo, E. (2001 ) “Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interaction with hexarelin, a nonnatural peptide GHS, and GH-releasing hormone”, Journal of Clinical Endocrinology and Metabolism 85, 4908–4911.
  • Asakawa, A., Inui, A., Kaga, T., Yuzuriha, H., Nagata, T., Fujimiya, M., Katsuura, G., Makino, S., Fujino, M.A. and Kasuga, M. (2001a ) “A role of ghrelin in neuroendocrine and behavioral responses to stress in mice”, Neuroendocrinology 74, 143–147.
  • Asakawa, A., Inui, A., Kaga, T., Yuzuriha, H., Nagata, T., Ueno, N., Makino, S., Fujimiya, M., Niijima, A., Fujino, M.A. and Kasuga, M. (2001b ) “Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin”, Gastroenterology 120, 337–345.
  • Bailey, A.R., Smith, R.G. and Leng, G. (1998 ) “The nonpeptide growth hormone secretagogue, MK-0677, activates hypothalamic arcuate nucleus neurons in vivo”, Journal of Neuroendocrinology 10, 111–118.
  • Baldanzi, G., Filigheddu, N., Cutrupi, S., Catapano, F., Bonissoni, S., Fubini, A., Malan, D., Baj, G., Granata, R., Broglio, F., Papotti, M., Surico, N., Bussolino, F., Isgaard, J., Deghenghi, R., Sinigaglia, F., Prat, M., Muccioli, G., Ghigo, E. and Graziani, A. (2002 ) “Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT”, Journal of Cell Biology 159, 1029–1037.
  • Barkan, A.L., Dimaraki, E.V., Jessup, S.K., Symons, K.V., Ermolenko, M. and Jaffe, C.A. (2003 ) “Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels”, Journal ofClinical Endocrinology and Metabolism 88, 2180–2184.
  • Batterham, R.L., Cohen, M.A., Ellis, S.M., le Roux, C.W., Withers, D. J., Frost, G.S., Ghatei, M.A. and Bloom, S.R. (2003 ) “Inhibition of food intake in obese subjects by peptide YY3- 36”, New England Journal of Medicine 349, 941–948.
  • Bedendi, I., Alloatti, G., Marcantoni, A., Malan, D., Catalano, F., Ghe, C., Deghenghi, R., Ghigo, E. and Muccioli, G. (2003 ) “Cardiac effects of ghrelin and its endogenous derivativesdes-octanoyl ghrelin and des-Gln14-ghrelin”, European Journal of Pharmacology 476, 87–95.
  • Bellone, S., Rapa, A., Vivenza, D., Vercellotti, A., Petri, A., Radetti, G., Bellone, J., Broglio, F., Ghigo, E. and Bona, G. (2003) “Circulating ghrelin levels in newborns are not associated to gender, body weight and hormonal parameters but depend on the type of delivery”, Journal of Endocrinological Investigations 26, RC9 -RC11.
  • Benso, A., Broglio, F., Marafetti, L., Lucatello, B., Seardo, M.A., Granata, R., Martina, V., Papotti, M. and Muccioli, G. (2004) Seminars in Vascular Medicine (Thieme Medical Publishers, 4, 107–114.
  • Bodart, V., Bouchard, J.F., McNicoll, N., Escher, E., Carriere, P., Ghigo, E., Sejlitz, T., Sirois, M.G., Lamontagne, D. and Ong, H. (1999 ) “Identification and characterization of a new growth hormone-releasing peptide receptor in the heart”, Circulation Research 85, 796–802.
  • Bodart, V., Febbraio, M., Demers, A., McNicoll, N., Pohankova, P., Perreault, A., Sejlitz, T., Escher, E., Silverstein, R.L., Lamontagne, D. and Ong, H. (2002 ) “CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart”, Circulation Research 90, 844–849.
  • Bowers, C.Y. (1998 ) “Growth hormone-releasing peptide (GHRP)”, Cellular and Molecular Life Sciences 54, 1316–1329.
  • Bowers, C.Y. (2001 ) “Unnatural growth hormone-releasing peptide begets natural ghrelin”, Journal of Clinical Endocrinology and Metabolism 86, 1464–1469.
  • Broglio, F., Arvat, E., Benso, A., Gottero, C., Muccioli, G., Papotti, M., Van der Lely, A.J., Deghenghi, R. and Ghigo, E. (2001 ) “Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans”, Journal of Clinical Endocrinology and Metabolism 86, 5083–5086.
  • Broglio, F., Van Koetsveld, P., Benso, A., Gottero, C., Prodam, F., Papotti, M., Cuccioli, G., Gauna, C., Hofland, L., Deghenghi, R., Arvat, E., Van der Lely, A.J. and Ghigo, E. (2002a ) “Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans”, Journal of Clinical Endocrinology and Metabolism 87, 4829–4832.
  • Broglio, F., Arvat, E., Benso, A., Gottero, C., Prodam, F., Grottoli, S., Papotti, M., Muccioli, G., Van der Lely, A.J., Deghenghi, R. and Ghigo, E. (2002b ) “Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans”, Journal of Clinical Endocrinology and Metabolism 87, 3783–3790.
  • Broglio, F., Benso, A., Gottero, C., Prodam, F., Gauna, C., Filtri, L., Arvat, E., Van der Lely, A.J., Deghenghi, R. and Ghigo, E. (2003a ) “Non-acylated ghrelin does not possess the pituitaric and pancreatic endocrine activity of acylated ghrelin in humans”, Journal of Endocrinological Investigations 26, 192–196.
  • Broglio, F., Benso, A., Castiglioni, C., Gottero, C., Prodam, F., Destefanis, S., Gauna, C., Van der Lely, A.J., Deghenghi, R., Bo, M., Arvat, E. and Ghigo, E. (2003b ) “The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects”, Journal of Clinical Endocrinology and Metabolism 88, 1537–1542.
  • Broglio, F., Gottero, C., Benso, A., Prodam, F., Destefanis, S., Gauna, C., Maccario, M., Deghenghi, R., Van der Lely, A.J. and Ghigo, E. (2003c ) “Effects of ghrelin on the insulin and glycemic responses to glucose, arginine, or free fatty acids load in humans”, Journal of Clinical Endocrinology and Metabolism 88, 4268–4272.
  • Broglio, F., Gottero, C., Benso, A., Prodam, F., Casanueva, F.F., Dieguez, C., Van der Lely, A.J., Deghenghi, R., Arvat, E. and Ghigo, E. (2003d ) “Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans”, Clinical Endocrinology (Oxf) 58, 92–98.
  • Broglio, F., Gianotti, L., Destefanis, S., Fassino, S., Abbate Daga, G., Mondelli, V., Lanfranco, F., Gottero, C., Gauna, C., Hofland, L., Van der Lely, A.J., Ghigo, E., “The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state”, Clinical Endocrinology (Oxf) 60, 592–599.
  • Burman, P., Ritzen, E.M. and Lindgren, A.C. (2001 ) “Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH”, Endocrine Reviews 22, 787–799.
  • Carlini, V.P., Monzon, M.E., Varas, M.M., Cragnolini, A.B., Schioth, H. B., Scimonelli, T.N. and de Barioglio, S.R. (2002 ) “Ghrelin increases anxiety-like behavior and memory retention in rats”, Biochemical and Biophysical Research and Communications 299, 739–743.
  • Chang, L., Ren, Y., Liu, X., Li, W.G., Yang, J., Geng, B., Weintraub, N.L. and Tang, C. (2004 ) “Protective effects of ghrelin on ischemia/reperfusion injury in the isolated rat heart”, Journal of Cardiovascular Pharmacology 43, 165–170.
  • Chapman, I.M., Bach, M.A., Van Cauter, E., Farmer, M., Krupa, D., Taylor, A.M., Schilling, L.M., Cole, K.Y., Skiles, E.H., Pezzoli, S.S., Hartman, M.L., Veldhuis, J.D., Gormley, G.J. and Thorner, M.O. (1996 ) “Stimulation of the growth hormone (GH)- insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects”, Journal of Clinical Endocrinology and Metabolism 81, 4249–4257.
  • Chen, H.Y., Trumbauer, M.E., Chen, A.S., Weingarth, D.T., Adams, J.R., Frazier, E.G., Shen, Z., Marsh, D.J., Feighner, S.D., Guan, X.M., Ye, Z., Nargund, R.P., Smith, R.G., Van der Ploeg, L.H., Howard, A.D., MacNeil, D.J. and Qian, S. (2004) “Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y (NPY) and agouti-related protein (AgRP)”, Endocrinology, 12, Feb.
  • Cohen, M.A., Ellis, S.M., le Roux, C.W., Batterham, R.L., Park, A., Patterson, M., Frost, G.S., Ghatei, M.A. and Bloom, S.R. (2003 ) “Oxyntomodulin suppresses appetite and reduces food intake in humans”, Journal of Clinical Endocrinology and Metabolism 88, 4696–4701.
  • Cummings, D.E. and Schwartz, M.W. (2001 ) “Genetics and pathophysiology of human obesity”, Annual Review of Medicine 54, 453–471.
  • Cummings, D.E., Purnell, J.Q., Frayo, R.S., Schmidova, K., Wisse, B. E. and Weigle, D.S. (2001 ) “A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans”, Diabetes 50, 1714–1719.
  • Cummings, D.E., Weigle, D.S., Frayo, R.S., Breen, P.A., Ma, M.K., Dellinger, E.P. and Purnell, J.Q. (2002a ) “Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery”, New England Journal of Medicine 346, 1623–1630.
  • Cummings, D.E., Clement, K., Purnell, J.Q., Vaisse, C., Foster, K.E., Frayo, R.S., Schwartz, M.W., Basdevant, A. and Weigle, D.S. (2002b ) “Elevated plasma ghrelin levels in Prader Willi syndrome”, Nature Medicine 8, 643–644.
  • Date, Y., Kojima, M., Hosoda, H., Sawaguchi, A., Mondal, M.S., Suganuma, T., Matsukura, S., Kangawa, K. and Nakazato, M. (2000 ) “Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans”, Endocrinology 141, 4255–4261.
  • Date, Y., Nakazato, M., Murakami, N., Kojima, M., Kangawa, K. and Matsukura, S. (2001 ) “Ghrelin acts in the central nervous system to stimulate gastric acid secretion”, Biochemical and Biophysical Research and Commununications 280, 904–907.
  • Date, Y., Nakazato, M., Hashiguchi, S., Dezaki, K., Mondal, M.S., Hosoda, H., Kojima, M., Kangawa, K., Arima, T., Matsuo, H., Yada, T. and Matsukura, S. (2002 ) “Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion”, Diabetes 51, 124–129.
  • Davis, M.E., Pemberton, C.J., Yandle, T.G., Lainchbury, J.G., Rademaker, M.T., Nicholls, M.G., Frampton, C.M. and Richards, A.M. (2004 ) “Urocortin-1 infusion in normal humans”, Journal of Clinical Endocrinology and Metabolism 89, 1402–1409.
  • Deghenghi, R., Papotti, M., Ghigo, E. and Muccioli, G. (2001) “Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland”, Journal of Endocrinological Investigations 24, RC1 -RC3.
  • DelParigi, A., Tschop, M., Heiman, M.L., Salbe, A.D., Vozarova, B., Sell, S.M., Bunt, J.C. and Tataranni, P.A. (2002) “High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader-Willi syndrome”, Journal of Clinical Endocrinology and Metabolism 87, 5461–5464.
  • Dickson, S.L. and Luckman, S.M. (1997a ) “Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6”, Endocrinology 138, 771–777.
  • Dickson, S.L., Leng, G. and Robinson, I.C. (1993 ) “Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neurons”, Neuroscience 53, 303–306.
  • Dickson, S.L., Leng, G. and Robinson, I.C. (1994 ) “Electrical stimulation of the rat periventricular nucleus influences the activity of hypothalamic arcuate neurones”, Journal of Neuroendocrinology 6, 359–367.
  • Dickson, S.L., Doutrelant-Viltart, O. and Leng, G. (1995a ) “GH-deficient dw/dw rats and lit/lit mice show increased Fos expression in the hypothalamic arcuate nucleus following systemic injection of GH-releasing peptide-6”, Journal of Endocrinology 146, 519–526.
  • Dickson, S.L., Leng, G., Dyball, R.E. and Smith, R.G. (1995b ) “Central actions of peptide and non-peptide growth hormone secretagogues in the rat”, Neuroendocrinology 61, 36–43.
  • Dickson, S.L., Doutrelant-Viltart, O., Dyball, R.E. and Leng, G. (1996 ) “Retrogradely labelled neurosecretory neurones of the rat hypothalamic arcuate nucleus express Fos protein following systemic injection of GH-releasing peptide-6”, Journal of Endocrinology 151, 323–331.
  • Dickson, S.L., Viltart, O., Bailey, A.R. and Leng, G. (1997 ) “Attenuation of the growth hormone secretagogue induction of Fos protein in the rat arcuate nucleus by central somatostatin action”, Neuroendocrinology 66, 188–194.
  • Egido, E.M., Rodriguez-Gallardo, J., Silvestre, R.A. and Marco, J. (2002 ) “Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion”, European Journal ofEndocrinology 146, 241–244.
  • Eiholzer, U., Nordmann, Y., l’Allemand, D., Schlumpf, M., Schmid, S. and Kromeyer-Hauschild, K. (2003) “Improving body composition and physical activity in Prader-Willi Syndrome”, Journal of Pediatrics 142, 73–78.
  • English, P.J., Ghatei, M.A., Malik, I.A., Bloom, S.R. and Wilding, J.P.H. (2002 ) “Food fails to suppress ghrelin levels in obese humans”, Journal of Clinical Endocrinology and Metabolism 87, 2984.
  • Enomoto, M., Nagaya, N., Uematsu, M., Okumura, H., Nakagawa, E. , Ono, F., Hosoda, H., Oya, H., Kojima, M., Kanmatsuse, K. and Kangawa, K. (2003) “Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans”, Clinical Science 105, 431–435.
  • Faulconbridge, L.F., Cummings, D.E., Kaplan, J.M. and Grill, H.J. (2003 ) “Hyperphagic effects of brainstem ghrelin administration”, Diabetes 52, 2260–2265.
  • Fehrentz, J.A., Martinez, J., Boeglin, D., Guerlavais, V. and Deghenghi, R. (2002 ) “Growth hormone secretagogues: past, present and future”, IDrugs 5, 804–814.
  • Flanagan, D.E., Evans, M.L., Monsod, T.P., Rife, F., Heptulla, R.A., Tamborlane, W.V. and Sherwin, R.S. (2003 ) “The influence of insulin on circulating ghrelin”, American Journal of Physiology- Endocrinology and Metabolism 284, E313–E316.
  • Foster, D.W. (1998 ), Chapter 76, In: Fauci, A.S., Braunwald, E., Iesselbacher, K.J., Wilson, J.D., Martin, J.B., Kasper, D.L., Haiser, S.L. and Longo, D.L., eds, Harrison’s Principles of Internal Medicine, 14th ed. (McGraw-Hill Inc., New York).
  • Frascarelli, S., Ghelardoni, S., Ronca-Testoni, S. and Zucchi, R. (2003 ) “Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart”, Basic Research in Cardiology 98, 401–405.
  • Funahashi, H., Takenoya, F., Guan, J.L., Kageyama, H., Yada, T. and Shioda, S. (2003 ) “Hypothalamic neuronal networks and feeding-related peptides involved in the regulation of feeding”, Anatomical Science International 78, 123–138.
  • Furuta, M., Funabashi, T. and Kimura, F. (2001 ) “Intra- cerebroventricular administration of ghrelin rapidly suppresses pulsatile luteinizing hormone secretion in ovariectomized rats”, Biochemical and Biophysical Research and Communications 288, 780–785.
  • Gaytan, F., Barreiro, M.L., Chopin, L.K., Herington, A.C., Morales, C., Pinilla, L., Casanueva, F.F., Aguilar, E., Dieguez, C. and Tena-Sempere, M. (2003 ) “Immunolocalization of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in the cyclic human ovary”, Journal of Clinical Endocrinology and Metabolism 88, 879–887.
  • Gehlert, D.R. (1999 ) “Role of hypothalamic neuropeptide Y in feeding and obesity”, Neuropeptides 33, 329–338.
  • Ghigo, E., Gianotti, L., Arvat, E., Ramunni, J., Valetto, M.R., Broglio, F., Rolla, M., Cavagnini, F. and Muller, E.E. (1999 ) “Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans”, Journal of Clinical Endocrinology and Metabolism 84, 285–290.
  • Gianotti, L., Lanfranco, F., Ramunni, J., Destefanis, S., Ghigo, E. and Arvat, E. (2002 ) “GH/IGF-I axis in anorexia nervosa”, Eating and weight disorders 7, 94–105.
  • Gnanapavan, S., Kola, B., Bustin, S.A., Morris, D.G., McGee, P., Fairclough, P., Bhattacharya, S., Carpenter, R., Grossman, A.B. and Korbonits, M. (2002 ) “The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans”, Journal of Clinical Endocrinology and Metabolism 87, 2988.
  • Hataya, Y., Akamizu, T., Takaya, K., Kanamoto, N., Ariyasu, H., Saijo, M., Moriyama, K., Shimatsu, A., Kojima, M., Kangawa, K. and Nakao, K. (2001 ) “A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH- releasing hormone in humans”, Journal of Clinical Endocrinology and Metabolism 86, 4552.
  • Hinney, A., Hoch, A., Geller, F., Schafer, H., Siegfried, W., Goldschmidt, H., Remschmidt, H. and Hebebrand, J. (2002 ) “Ghrelin gene: identification of missense variants and a frameshift mutation in extremely obese children and adolescents and healthy normal weight students”, Journal of Clinical Endocrinology and Metabolism 87, 2716.
  • Horvath, T.L., Diano, S., Sotonyi, P., Heiman, M. and Tschop, M. (2001 ) “Minireview: ghrelin and the regulation of energy balance—a hypothalamic perspective”, Endocrinology 142, 4163–4169.
  • Hosoda, H., Kojima, M., Mizushima, T., Shimizu, S. and Kangawa, K. (2002 ) “Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post- translational processing”, Journal of Biological Chemistry 278, 64–70.
  • Jeffery, P.L., Herington, A.C. and Chopin, L.K. (2003 ) “The potential autocrine/paracrine roles of ghrelin and its receptor in hormone-dependent cancer”, Cytokine and Growth Factor Reviews 14, 113–122.
  • Kalra, S.P., Dube, M.G., Pu, S., Xu, B., Horvath, T.L. and Kalra, P.S. (1999 ) “Interacting appetite-regulating pathways in the hypothalamic regulation of body weight”, Endocrine Reviews 20, 68–100.
  • Kamegai, J., Tamura, H., Shimizu, T., Ishii, S., Sugihara, H. and Wakabayashi, I. (2000 ) “Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression”, Endocrinology 141, 4797–4800.
  • Kamegai, J., Tamura, H., Shimizu, T., Ishii, S., Sugihara, H. and Wakabayashi, I. (2001 ) “Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and agouti-related protein mRNA levels and body weight in rats”, Diabetes 50, 2438–2443.
  • Kaplan, H.I., Sadock, B.J. and Grebb, J.A. (1997) Kaplan & Sadock’s Synopsis of Psychiatry Behavioural Sciences, Clinical Psychiatry, 7th ed. (Williams & Wilkins, Baltimore ), pp 689–695.
  • Kirk, S.E., Gertz, B.J., Schneider, S.H., Hartman, M.L., Pezzoli, S.S., Wittreich, J.M., Krupa, D.A., Seibold, J.R. and Thorner, M.O. (1997 ) “Effect of obesity and feeding on the growth hormone (GH) response to the GH secretagogue L-692,429 in young men”, Journal of Clinical Endocrinology and Metabolism 82, 1154–1159.
  • Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H. and Kangawa, K. (1999 ) “Ghrelin is a growth-hormone-releasing acylated peptide from stomach”, Nature 402, 656–660.
  • Kojima, M., Hosoda, H. and Kangawa, K. (2001a ) “Purification and distribution of ghrelin: the natural endogenous ligand for the growth hormone secretagogue receptor”, Hormon Research 56(Suppl. 1), 93–97.
  • Kojima, M., Hosoda, H., Matsuo, H. and Kangawa, K. (2001b ) “Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor”, Trends in Endocrinology and Metabolism 12, 118–122.
  • Korbonits, M., Gueorguiev, M., O’Grady, E., Lecoeur, C., Swan, D. C., Mein, C.A., Weill, J., Grossman, A.B. and Froguel, P. (2002 ) “A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children”, Journal of Clinical Endocrinology and Metabolism 87, 4005–4008.
  • Leal-Cerro, A., Torres, E., Soto, A., Dios, E., Deghenghi, R., Arvat, E., Ghigo, E., Dieguez, C. and Casanueva, F.F. (2002 ) “Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing’s syndrome but instead induces exaggerated corticotropin and cortisol responses”, Neuroendocrinology 76, 390–396.
  • Lee, H.M., Wang, G., Englander, E.W., Kojima, M. and Greeley, G.H., Jr. (2002 ) “Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations”, Endocrinology 143, 185–190.
  • Lippl, F., Kircher, F., Erdmann, J., Allescher, H.D. and Schusdziarra, V. (2004 ) “Effect of GIP, GLP-1, insulin and gastrin on ghrelin release in the isolated rat stomach”, Regulatory Peptides 119, 93–98.
  • Lissett, C.A. and Shalet, S.M. (2000) “Effects of growth hormone on bone and muscle”, Growth Hormone and IGF Research 10(Suppl. B), S95–101.
  • Locke, W., Kirgis, H.D., Bowers, C.Y. and Abdoh, A.A. (1995 ) “Intracerebroventricular growth-hormone-releasing peptide- 6 stimulates eating without affecting plasma growth hormone responses in rats”, Life Science 56, 1347–1352.
  • Lucidi, P., Murdolo, G., Di Loreto, C., de Cicco, A., Parlanti, N., Fanelli, C., Santeusanio, F., Bolli, G.B. and de Feo, P. (2002 ) “Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia”, Diabetes 51, 2911–2914.
  • Luckman, S.M., Rosenzweig, I. and Dickson, S.L. (1999 ) “Activation of arcuate nucleus neurons by systemic administration of leptin and growth hormone-releasing peptide-6 in normal and fasted rats”, Neuroendocrinology 70, 93–100.
  • Maccario, M., Tassone, F., Grottoli, S., Rossetto, R., Gauna, C. and Ghigo, E. (2002 ) “Neuroendocrine and metabolic determinants of the adaptation of GH/IGF-I axis to obesity”, Annals of Endocrinology (Paris) 63, 140–144.
  • Marks, D.L. and Cone, R.D. (2001 ) “Central melanocortins and the regulation of weight during acute and chronic disease”, Recent Progress in Hormone Research 56, 359–375.
  • Masuda, A., Shibasaki, T., Hotta, M., Suematsu, H. and Shizume, K. (1988 ) “Study on the mechanism of abnormal growth hormone (GH) secretion in anorexia nervosa: no evidence of involvement of a low somatomedin-C level in the abnormal GH secretion”, Journal of Endocrinological Investigations 11, 297–302.
  • Masuda, Y., Tanaka, T., Inomata, N., Ohnuma, N., Tanaka, S., Itoh, Z., Hosoda, H., Kojima, M. and Kangawa, K. (2000 ) “Ghrelin stimulates gastric acid secretion and motility in rats”, Biochemical and Biophysical Research and Communications 276, 905–908.
  • Matsumura, K., Tsuchihashi, T., Fujii, K., Abe, I. and Iida, M. (2002 ) “Central ghrelin modulates sympathetic activity in conscious rabbits”, Hypertension 40, 694–699.
  • Matsumura, K., Tsuchihashi, T., Fujii, K. and Iida, M. (2003 ) “Neural regulation of blood pressure by leptin and the related peptides”, Regulatory Peptides 114, 79–86.
  • McCowen, K.C., Maykel, J.A., Bistrian, B.R. and Ling, P.R. (2002) “Circulating ghrelin concentrations are lowered by intravenous glucose or hyperinsulinemic euglycemic conditions in rodents”, Journal of Endocrinology 175, R7–11.
  • Merchenthaler, I. (1991 ) “Neurons with access to the general circulation in the central nervous system of the rat: a retrograde tracing study with fluoro-gold”, Neuroscience 44, 655–662.
  • Mohlig, M., Spranger, J., Otto, B., Ristow, M., Tschop, M. and Pfeiffer, A.F. (2002) “Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans”, Journal of Endocrinological Investigations 25, RC36 -RC38.
  • Muccioli, G., Broglio, F., Valetto, M.R., Ghe, C., Catapano, F., Graziani, A., Papotti, M., Bisi, G., Deghenghi, R. and Ghigo, E. (2000 ) “Growth hormone-releasing peptides and the cardiovascular system”, Annales d’Endocrinologie (Paris) 61, 27–31.
  • Muccioli, G., Tschop, M., Papotti, M., Deghenghi, R., Heiman, M. and Ghigo, E. (2002 ) “Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity”, European Journal of Pharmacology 440, 235–254.
  • Muller, A.F., Lamberts, S.W., Janssen, J.A., Hofland, L.J., Koetsveld, P.V., Bidlingmaier, M., Strasburger, C.J., Ghigo, E. and Van der Lely, A.J. (2002) “Ghrelin drives GH secretion during fasting in man”, European Journal of Endocrinology 146, 203–207.
  • Murdolo, G., Lucidi, P., Di Loreto, C., Parlanti, N., de Cicco, A., Fatone, C., Fanelli, C.G., Bolli, G.B., Santeusanio, F. and de Feo, P. (2003 ) “Insulin is required for prandial ghrelin suppression in humans”, Diabetes 52, 2923–2927.
  • Nagaya, N., Miyatake, K., Uematsu, M., Oya, H., Shimizu, W., Hosoda, H., Kojima, M., Nakanishi, N., Mori, H. and Kangawa, K. (2001a ) “Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure”, Journal of Clinical Endocrinology and Metabolism 86, 5854–5859.
  • Nagaya, N., Uematsu, M., Kojima, M., Ikeda, Y., Yoshihara, F., Shimizu, W., Hosoda, H., Hirota, Y., Ishida, H., Mori, H. and Kangawa, K. (2001b ) “Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure”, Circulation 104, 1430–1435.
  • Nagaya, N., Kojima, M., Uematsu, M., Yamagishi, M., Hosoda, H., Oya, H., Hayashi, Y. and Kangawa, K. (2001c) “Hemodynamic and hormonal effects of human ghrelin in healthy volunteers”, American Journal of PhysiologyRegulatory, Integrative and Comparative Physiology 280, R1483 -R1487.
  • Nakazato, M., Murakami, N., Date, Y., Kojima, M., Matsuo, H., Kangawa, K. and Matsukura, S. (2001 ) “A role for ghrelin in the central regulation of feeding”, Nature 409, 194–198.
  • Nativio, D.G. (2002 ) “The genetics, diagnosis, and management of Prader-Willi syndrome”, Journal of Pediatric Health Care 16, 298–303.
  • Nedvidkova, J., Krykorkova, I., Bartak, V., Papezova, H., Gold, P.W., Alesci, S. and Pacak, K. (2003 ) “Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa”, Journal of Clinical Endocrinology and Metabolism 88, 1678–1682.
  • Okada, K., Ishii, S., Minami, S., Sugihara, H., Shibasaki, T. and Wakabayashi, I. (1996 ) “Intracerebroventricular administration of the growth hormone-releasing peptide KP-102 increases food intake in free-feeding rats”, Endocrinology 137, 5155–5158.
  • Ong, H., Tremblay, A., Febbraio, M. et al. Growth Hormone- Releasing Peptides as inhibitorsof fatty streaks formation: a new therapy for atherosclerosis. In: 85th Annual Meeting of the Endocrine Society, Philadelphia, Pennsylvania 2003; abs. P2–223
  • Otto, B., Cuntz, U., Fruehauf, E., Wawarta, R., Folwaczny, C., Riepl, R.L., Heiman, M.L., Lehnert, P., Fichter, M. and Tschop, M. (2001 ) “Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa”, European Journal of Endocrinology 145, 669–673.
  • Papotti, M., Ghe, C., Cassoni, P., Catapano, F., Deghenghi, R., Ghigo, E. and Muccioli, G. (2000 ) “Growth hormone secreta- gogue binding sites in peripheral human tissues”, Journal of Clinical Endocrinology and Metabolism 85,3803–3807.
  • Papotti, M., Cassoni, P., Volante, M., Deghenghi, R., Muccioli, G. and Ghigo, E. (2001 ) “Ghrelin-producing endocrine tumors of the stomach and intestine”, Journal of Clinical Endocrinology and Metabolism 86, 5052–5059.
  • Pemberton, C., Wimalasena, P., Yandle, T., Soule, S. and Richards, M. (2003 ) “C-terminal pro-ghrelin peptides are present in the human circulation”, Biochemical and Biophysical Research and Community 310, 567–573.
  • Pombo, M., Maccario, M., Seoane, L.M., Tovar, S., Micic, D., Ghigo, E. , Casanueva, F.F. and Dieguez, C. (2001) “Control and function of the GH/IGF-I axis in obesity”, Eating and weight Disorders 6, 22–27.
  • Popovic, V., Miljic, D., Micic, D., Damjanovic, S., Arvat, E., Ghigo, E., Dieguez, C. and Casanueva, F.F. (2003 ) “Ghrelin main action on the regulation of growth hormone release is exerted at hypothalamic level”, Journal of Clinical Endocrinology and Metabolism 88, 3450–3453.
  • Poykko, S.M., Kellokoski, E., Horkko, S., Kauma, H., Kesaniemi, Y.A. and Ukkola, O. (2003 ) “Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes”, Diabetes 52, 2546–2553.
  • Reimer, M.K., Pacini, G. and Ahren, B. (2003 ) “Dose-dependent inhibition by ghrelin of insulin secretion in the mouse”, Endocrinology 144, 916–921.
  • Rigamonti, A.E., Pincelli, A.I., Corra, B., Viarengo, R., Bonomo, S.M., Galimberti, D., Scacchi, M., Scarpini, E., Cavagnini, F. and Muller, E.E. (2002) “Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients”, Journal of Endocrinology 175, R1 -R5.
  • Rolla, M., Andreoni, A., Belliti, D., Cristofani, R., Ferdeghini, M. and Muller, E.E. (1991 ) “Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorders”, Biological Psychiatry 29, 1079–1091.
  • Rossoni, G., de Gennaro Colonna, V., Bernareggi, M., Polvani, G.L., Muller, E.E. and Berti, F. (1998 ) “Protectant activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats”, Journal of Cardiovascular Pharmacology 32, 260–265.
  • Sainsbury, A., Cooney, G.J. and Herzog, H. (2002 ) “Hypothalamic regulation of energy homeostasis”, Best Practice and Research Clinical Endocrinology and Metabolism 16, 623–637.
  • Sasano, H. (1998 ) “Glycogen and liver dysfunction in anorexia nervosa”, Internal Medicine 37, 652–657.
  • Shiiya, T., Nakazato, M., Mizuta, M., Date, Y., Mondal, M.S., Tanaka, M., Nozoe, S., Hosoda, H., Kangawa, K. and Matsukura, S. (2002 ) “Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion”, Journal of Clinical Endocrinology Metabolism 87, 240–244.
  • Shimizu, Y., Nagaya, N., Teranishi, Y., Imazu, M., Yamamoto, H., Shokawa, T., Kangawa, K., Kohno, N. and Yoshizumi, M. (2003 ) “Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats”, Biochemical and Biophysical Research and Communications 310, 830–835.
  • Shintani, M., Ogawa, Y., Ebihara, K., Aizawa-Abe, M., Miyanaga, F., Takaya, K., Hayashi, T., Inoue, G., Hosoda, K., Kojima, M., Kangawa, K. and Nakao, K. (2001 ) “Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway”, Diabetes 50, 227–232.
  • Smith, R.G., Van der Ploeg, L.H., Howard, A.D., Feighner, S.D., Cheng, K., Hickey, G.J., Wyvratt, Jr., M.J., Fisher, M.H., Nargund, R.P. and Patchett, A.A. (1997 ) “Peptidomimetic regulation of growth hormone secretion”, Endocrine Review 18, 621–645.
  • Smith, R.G., Leonard, R., Bailey, A.R., Palyha, O., Feighner, S., Tan, C. , Mckee, K.K., Pong, S.S., Griffin, P. and Howard, A. (2001) “Growth hormone secretagogue receptor family members and ligands”, Endocrine 14, 9–14.
  • Spiegelman, B.M. and Flier, J.S. (2001 ) “Obesity and the regulation of energy balance”, Cell 104, 531–543.
  • Steiger, A. (2003 ) “Sleep and endocrine regulation”, Frontiers in Bioscience 8, s358–s376.
  • Stoving, R.K., Veldhuis, J.D., Flyvbjerg, A., Vinten, J., Hangaard, J., Koldkjaer, O.G., Kristiansen, J. and Hagen, K. (1999a ) “Jontly amplified basal and pulsatile growth hormone (GH) secretion and increased process irregularity in women with anorexia nervosa: indirect evidence for disruption of feedback regulation within the GH-insulin-like growth factor I axis”, Journal of Clinical Endocrinology and Metabolism 81, 2056–2063.
  • Stoving, R.K., Hangaard, J., Habsen-Nord, M. and Hagen, C. (1999b ) “A review of endocrine change in anorexia nervosa”, Journal of Psychiatric Research 33, 139–152.
  • Sugino, T., Yamaura, J., Yamagishi, M., Kurose, Y., Kojima, M., Kangawa, K., Hasegawa, Y. and Terashima, Y. (2003 ) “Involvement of cholinergic neurons in the regulation of the ghrelin secretory response to feeding in sheep”, Biochemical and Biophysical Research and Communications 304, 308–312.
  • Svensson, J., Lonn, L., Jansson, J.O., Murphy, G., Wyss, D., Krupa, D., Cerchio, K., Polvino, W., Gertz, B., Boseaus, I., Sjostrom, L. and Bengtsson, B.A. (1998 ) “Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure”, Journal of Clinical Endocrinology and Metabolism 83, 362–369.
  • Tanaka, M., Naruo, T., Muranaga, T., Yasuhara, D., Shiiya, T., Nakazato, M., Matsukura, S. and Nozoe, S. (2002) “Increased fasting plasma ghrelin levels in patients with bulimia nervosa”, European Journal of Endocrinology 146, R1 -R3.
  • Tanaka, M., Naruo, T., Nagai, N., Kuroki, N., Shiiya, T., Nakazato, M., Matsukura, S. and Nozoe, S. (2003 ) “Habitual binge/ purge behavior influences circulating ghrelin levels in eating disorders”, Journal of Psychiatric Research 37, 17–22.
  • Tassone, F., Broglio, F., Destefanis, S., Rovere, S., Benso, A., Gottero, C., Prodam, F., Rossetto, R., Gauna, C., Van der Lely, A.J., Ghigo, E. and Maccario, M. (2003 ) “Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity”, Journal of Clinical Endocrinology and Metabolism 88, 5478–5483.
  • Tena-Sempere, M., Barreiro, M.L., Gonzalez, L.C., Gaytan, F., Zhang, F.P., Caminos, J.E., Pinilla, L., Casanueva, F.F., Dieguez, C. and Aguilar, E. (2002 ) “Novel expression and functional role of ghrelin in rat testis”, Endocrinology 143, 717–725.
  • Thompson, N.M., Gill, D.A., Davies, R., Loveridge, N., Houston, P.A., Robinson, I.C. and Wells, T. (2003) “Ghrelin and des- octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of GHS-R1a”, Endocrinology, [Epub ahead of print].
  • Thorner, M.O., Chapman, I.M., Gaylinn, B.D., Pezzoli, S.S. and Hartman, M.L. (1997 ) “Growth hormone-releasing hormone and growth hormone-releasing peptide as therapeutic agents to enhance growth hormone secretion in disease and aging”, Recent Progress in Hormone Research 52, 215–244.
  • Tolle, V., Bassant, M.H., Zizzari, P., Poindessous-Jazat, F., Tomasetto, C., Epelbaum, J. and Bluet-Pajot, M.T. (2002 ) “Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats”, Endocrinology 143, 1353–1361.
  • Tomasetto, C., Karam, S.M., Ribieras, S., Masson, R., Lefebvre, O., Staub, A., Alexander, G., Chenard, M.P. and Rio, M.C. (2000 ) “Identification and characterization of a novel gastric peptide hormone: the motilin-related peptide”, Gastroenterology 119, 395–405.
  • Torsello, A., Locatelli, V., Melis, M.R., Succu, S., Spano, M.S., Deghenghi, R., Muller, E.E. and Argiolas, A. (2000 ) “Differential orexigenic effects of hexarelin and its analogs in the rat hypothalamus: indication for multiple growth hormone secretagogue receptor subtypes”, Neuroendocrinology 72, 327–332.
  • Torsello, A., Bresciani, E., Rossoni, G., Avallone, R., Tulipano, G., Cocchi, D., Bulgarelli, I., Deghenghi, R., Berti, F. and Locatelli, V. (2003 ) “Ghrelin plays a minor role in the physiological control of cardiac function in the rat”, Endocrinology 144, 1787–1792.
  • Toshinai, K., Mondal, M.S., Nakazato, M., Date, Y., Murakami, N., Kojima, M., Kangawa, K. and Matsukura, S. (2001 ) “Upregu- lation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration”, Biochemical and Biophysical Research and Communications 281, 1220–1225.
  • Tritos, N.A. and Maratos-Flier, E. (1999 ) “Two important systems in energy homeostasis: melanocortins and melanin- concentrating hormone”, Neuropeptides 33, 339–349.
  • Tritos, N.A., Kissinger, K.V., Manning, W.J. and Danias, P.G. (2004 ) “Association between ghrelin and cardiovascular indexes in healthy obese and lean men”, Clinical Endocrinology 60, 60–66.
  • Tschop, M., Smiley, D.L. and Heiman, M.L. (2000 ) “Ghrelin induces adiposity in rodents”, Nature 407, 908–913.
  • Tschop, M., Weyer, C., Tataranni, P.A., Devanarayan, V., Ravussin, E. and Heiman, M.L. (2001 ) “Circulating ghrelin levels are decreased in human obesity”, Diabetes 50, 707–709.
  • Tschop, M., Statnick, M.A., Suter, T.M. and Heiman, M.L. (2002 ) “GH-releasing peptide-2 increases fat mass in mice lacking NPY: indication for a crucial mediating role of hypothalamic agouti-related protein”, Endocrinology 143, 558–568.
  • Tung, Y.C., Hewson, A.K. and Dickson, S.L. (2001 ) “Actions of leptin on growth hormone secretagogue-responsive neurones in the rat hypothalamic arcuate nucleus recorded in vitro”, Journal of Neuroendocrinology 13, 209–215.
  • Ukkola, O. and Poykko, S. (2002 ) “Ghrelin, growth and obesity”, Annals de Medicine 34, 102–108.
  • Volante, M., Allia, E., Gugliotta, P., Funaro, A., Broglio, F., Deghenghi, R., Muccioli, G., Ghigo, E. and Papotti, M. (2002 ) “Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors”, Journal of Clinical Endocrinology and Metabolism 87, 1300–1308.
  • Volante, M., Allia, E., Fulcheri, E., Cassoni, P., Ghigo, E., Muccioli, G. and Papotti, M. (2003 ) “Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth”, American Journal of Pathology 162, 645–654.
  • Wierup, N., Svensson, H., Mulder, H. and Sundler, F. (2002 ) “The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas”, Regulatory Peptides 107, 63–69.
  • Wiley, K.E. and Davenport, A.P. (2002 ) “Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1”, British Journal of Pharmacology 136, 1146–1152.
  • Willesen, M.G., Kristensen, P. and Romer, J. (1999 ) “Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat”, Neuroendocrinology 70, 306–316.
  • Wren, A.M., Small, C.J., Abbott, C.R., Dhillo, W.S., Seal, L.J., Cohen, M.A., Batterham, R.L., Taheri, S., Stanley, S.A., Ghatei, M.A. and Bloom, S.R. (2001 ) “Ghrelin causes hyperphagia and obesity in rats”, Diabetes 50, 2540–2547.
  • Wren, A.M., Small, C.J., Fribbens, C.V., Neary, N.M., Ward, H.L., Seal, L.J., Ghatei, M.A. and Bloom, S.R. (2002 ) “The hypothalamic mechanisms of the hypophysiotropic action of ghrelin”, Neuroendocrinology 76, 316–324.
  • Yamazaki, M., Nakamura, K., Kobayashi, H., Matsubara, M., Hayashi, Y., Kangawa, K. and Sakai, T. (2002 ) “Regulational effect of ghrelin on growth hormone secretion from perifused rat anterior pituitary cells”, Journal of Neuroendocrinology 14, 156–162.
  • Yoshihara, F., Kojima, M., Hosoda, H., Nakazato, M. and Kangawa, K. (2002 ) “Ghrelin: a novel peptide for growth hormone release and feeding regulation”, Current Opinion in Clinical Nutrition and Metabolic Care 5, 391–395.
  • Zigman, J.M. and Elmquist, J.K. (2003 ) “Minireview: From anorexia to obesity—the yin and yang of body weight control”, Endocrinology 144, 3749–3756.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.